ENTRY       D04127                      Drug
NAME        Dalfampridine (USAN);
            Fampridine (JAN/INN);
            4-Aminopyridine;
            Neurelan (TN);
            Ampyra (TN);
            Fampyra (TN)
PRODUCT     AMPYRA (Acorda Therapeutics)
  GENERIC   DALFAMPRIDINE (Accord Healthcare)
            DALFAMPRIDINE (Actavis Pharma)
            DALFAMPRIDINE (Ascend Laboratories)
            DALFAMPRIDINE (Aurobindo Pharma Limited)
            DALFAMPRIDINE (Bryant Ranch Prepack)
            DALFAMPRIDINE (Golden State Medical Supply)
            DALFAMPRIDINE (Hikma Pharmaceuticals USA)
            DALFAMPRIDINE (Micro Labs Limited)
            DALFAMPRIDINE (Mylan Pharmaceuticals)
            DALFAMPRIDINE (Sun Pharmaceutical Industries)
FORMULA     C5H6N2
EXACT_MASS  94.0531
MOL_WEIGHT  94.1145
REMARK      Same as: C13728
            ATC code: N07XX07
            Product: D04127<US>
EFFICACY    Convulsant inducer, Potassium channel blocker
  DISEASE   Multiple sclerosis [DS:H01490]
COMMENT     Multiple sclerosis symptomatic treatment
TARGET      KCNA [HSA:3736 3737 3738 3739 3741 3742 3743 3744] [KO:K04874 K04875 K04876 K04877 K04878 K04879 K04880 K04881]
            KCNB [HSA:3745 9312] [KO:K04885 K04886]
            KCNC [HSA:3746 3747 3748 3749] [KO:K04887 K04888 K04889 K04890]
            KCND [HSA:3750 3751 3752] [KO:K04891 K04892 K04893]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07X OTHER NERVOUS SYSTEM DRUGS
                N07XX Other nervous system drugs
                 N07XX07 Fampridine
                  D04127  Dalfampridine (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Multiple Sclerosis Agents
               Dalfampridine
                D04127  Dalfampridine (USAN)
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Potassium channels
                KCNA
                 D04127  Dalfampridine (USAN) &lt;US&gt;
                KCNB
                 D04127  Dalfampridine (USAN) &lt;US&gt;
                KCNC
                 D04127  Dalfampridine (USAN) &lt;US&gt;
                KCND
                 D04127  Dalfampridine (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04127
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04127
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04127
DBLINKS     CAS: 504-24-5
            PubChem: 47206074
            ChEBI: 34385
            PDB-CCD: 4AP
            LigandBox: D04127
            NIKKAJI: J1.568G
ATOM        7
            1   C8x C    21.6064  -17.8079
            2   C8x C    21.6064  -19.2083
            3   N5x N    22.8220  -19.9085
            4   C8x C    24.0305  -19.2083
            5   C8x C    24.0305  -17.8079
            6   C8y C    22.8220  -17.1078
            7   N1a N    22.8239  -15.7075
BOND        7
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     6   1 1
            7     6   7 1
///
